209 related articles for article (PubMed ID: 25425479)
1. Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development.
Kawakami H; Maeda T; Abe N; Matsumoto Y; Mitsuhashi Y; Tsuboi R; Okubo Y
J Dermatol; 2015 Jan; 42(1):94-5. PubMed ID: 25425479
[No Abstract] [Full Text] [Related]
2. Case of recalcitrant nail psoriasis unresponsive to adalimumab but successfully treated with infliximab.
Satoh M; Yamamoto T
J Dermatol; 2017 Nov; 44(11):e288-e289. PubMed ID: 28636140
[No Abstract] [Full Text] [Related]
3. Complete reversion of anti-infliximab immunization by methotrexate combination in a patient with psoriasis.
Vincent T; Best M; Plawecki M; Girard C
J Dermatol; 2015 Oct; 42(10):1030-1. PubMed ID: 26119228
[No Abstract] [Full Text] [Related]
4. Biologic response modifiers and pediatric psoriasis.
Bellodi Schmidt F; Shah KN
Pediatr Dermatol; 2015; 32(3):303-20. PubMed ID: 25727936
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis.
Quistrebert J; Hässler S; Bachelet D; Mbogning C; Musters A; Tak PP; Wijbrandts CA; Herenius M; Bergstra SA; Akdemir G; Johannesson M; Combe B; Fautrel B; Chollet-Martin S; Gleizes A; Donnellan N; Deisenhammer F; Davidson J; Hincelin-Mery A; Dönnes P; Fogdell-Hahn A; De Vries N; Huizinga T; Abugessaisa I; Saevarsdottir S; Hacein-Bey-Abina S; Pallardy M; Broët P; Mariette X;
Semin Arthritis Rheum; 2019 Jun; 48(6):967-975. PubMed ID: 30420245
[TBL] [Abstract][Full Text] [Related]
6. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
Wald JM; Klufas DM; Strober BE
J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
[TBL] [Abstract][Full Text] [Related]
7. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.
Bissonnette R; Maari C; Barber K; Lynde CW; Vender R
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1576-81. PubMed ID: 25600828
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
Atzeni F; Leccese P; D'Angelo S; Sarzi-Puttini P; Olivieri I
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S94. PubMed ID: 20868581
[No Abstract] [Full Text] [Related]
9. Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure.
Martínez Feito A; Plasencia-Rodríguez C; Navarro-Compán V; Hernández-Breijo B; Nozal P; Ángeles González M; Nuño L; Monjo I; Pascual-Salcedo D; Balsa A
Semin Arthritis Rheum; 2020 Feb; 50(1):E1-E2. PubMed ID: 31375255
[No Abstract] [Full Text] [Related]
10. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
[TBL] [Abstract][Full Text] [Related]
11. Genetic prediction of the effectiveness of biologics for psoriasis treatment.
Nishikawa R; Nagai H; Bito T; Ikeda T; Horikawa T; Adachi A; Matsubara T; Nishigori C
J Dermatol; 2016 Nov; 43(11):1273-1277. PubMed ID: 27129929
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab administration after infliximab therapy is a successful treatment strategy for generalized pustular psoriasis.
Matsumoto A; Komine M; Karakawa M; Kishimoto M; Ohtsuki M
J Dermatol; 2017 Feb; 44(2):202-204. PubMed ID: 27743397
[TBL] [Abstract][Full Text] [Related]
13. Long-term management of generalized pustular psoriasis with infliximab: case series.
Routhouska SB; Sheth PB; Korman NJ
J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
Mori Y; Kuwahara Y; Chiba S; Itoi E
Mod Rheumatol; 2015 May; 25(3):431-4. PubMed ID: 25295919
[TBL] [Abstract][Full Text] [Related]
15. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?
Murdaca G; Spanò F; Contatore M; Guastalla A; Penza E; Magnani O; Puppo F
Expert Opin Drug Saf; 2016 Jan; 15(1):43-52. PubMed ID: 26559805
[TBL] [Abstract][Full Text] [Related]
17. The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.
Tabolli S; Giannantoni P; Paradisi A; Abeni D
Br J Dermatol; 2015 Jul; 173(1):256-8. PubMed ID: 25422080
[No Abstract] [Full Text] [Related]
18. Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.
Ovejero-Benito MC; Prieto-Pérez R; Llamas-Velasco M; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Talegón M; Cabaleiro T; Daudén E; Abad-Santos F
Pharmacogenomics; 2018 Jan; 19(1):7-16. PubMed ID: 29192552
[TBL] [Abstract][Full Text] [Related]
19. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
20. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.
Gallo E; Llamas-Velasco M; Daudén E; García-Diez A
Int J Dermatol; 2013 Dec; 52(12):1610-1. PubMed ID: 22834488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
